The Expanded Access Program for the treatment of COVID-19 would not have been possible or successful without the acute care facilities, blood collection centers and health care providers who provided access to convalescent plasma for thousands of patients who were enrolled in the program.
The data collected can inform future clinical trials on the efficacy of convalescent plasma therapy for COVID-19.
View the names of participating locations and enrolled providers (PDF).
View a graphical representation of enrolled patients, blood banks and hospitals by county in the United States. (PDF)